MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells

References

• Jordan JT, Gerstner ER, Batchelor TT, Cahill DP, Plotkin SR. Glioblastoma care in the elderly. Cancer. 2016;122:189-97. doi:10.1002/cncr.29742. PMID:26618888
   PubMed Web of Science ®Google Scholar
• Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29:1203-17. doi:10.1101/gad.261982.115. PMID:26109046
   PubMed Web of Science ®Google Scholar
• Wait SD, Prabhu RS, Burri SH, Atkins TG, Asher AL. Polymeric drug delivery for the treatment of glioblastoma. Neuro-Oncol. 2015;17 Suppl 2:ii9-ii23. doi:10.1093/neuonc/nou360. PMID:25746091
   PubMed Web of Science ®Google Scholar
• Han J, Chen Q. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells. Int J Clin Exp Pathol. 2015;8:12698-707. PMID:26722459
   PubMed Web of Science ®Google Scholar
• Huang D, Duan H, Huang H, Tong X, Han Y, Ru G, Qu L, Shou C, Zhao Z. Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition. Scientific Reports. 2016;6:20502. doi:10.1038/srep20502. PMID:26846307
   PubMed Web of Science ®Google Scholar
• Liu Y, Du F, Zhao Q, Jin J, Ma X, Li H. Acquisition of 5-fluorouracil resistance induces epithelial-mesenchymal transitions through the Hedgehog signaling pathway in HCT-8 colon cancer cells. Oncol Letters. 2015;9:2675-9
   PubMed Web of Science ®Google Scholar
• Lin JJ, Zhao TZ, Cai WK, Yang YX, Sun C, Zhang Z, Xu YQ, Chang T, Li ZY. Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition. Oncotarget. 2015;6:17107-20. doi:10.18632/oncotarget.3672. PMID:25940798
   PubMed Web of Science ®Google Scholar
• Han MZ, Huang B, Chen AJ, Zhang X, Xu R, Wang J, Li XG. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas. Oncol Reports. 2017;37:903-12
   PubMed Web of Science ®Google Scholar
• Lee KH, Ahn EJ, Oh SJ, Kim O, Joo YE, Bae JA, Yoon S, Ryu HH, Jung S, Kim KK, et al. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers. Oncotarget. 2015;6:3240-53. doi:10.18632/oncotarget.3087. PMID:25605251
   PubMed Web of Science ®Google Scholar
• Gomes BC, Rueff J, Rodrigues AS. MicroRNAs and cancer drug resistance. Methods Mol Biol. 2016;1395:137-62. doi:10.1007/978-1-4939-3347-1_9. PMID:26910073
   PubMedGoogle Scholar
• Riquelme I, Letelier P, Riffo-Campos AL, Brebi P, Roa JC. Emerging Role of miRNAs in the drug resistance of gastric cancer. Int J Mol Sci. 2016;17:424. doi:10.3390/ijms17030424. PMID:27011182
   PubMed Web of Science ®Google Scholar
• Xu Y, Huang J, Ma L, Shan J, Shen J, Yang Z, Liu L, Luo Y, Yao C, Qian C. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways. Cancer Letters. 2016;371:171-81. doi:10.1016/j.canlet.2015.11.034. PMID:26655273
   PubMed Web of Science ®Google Scholar
• van Jaarsveld MT, van Kuijk PF, Boersma AW, Helleman J, van IWF, Mathijssen RH, Pothof J, Berns EM, Verweij J, Wiemer EA. miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 2015;14:196. doi:10.1186/s12943-015-0464-4. PMID:26576679
   PubMed Web of Science ®Google Scholar
• Stojcheva N, Schechtmann G, Sass S, Roth P, Florea AM, Stefanski A, Stuhler K, Wolter M, Muller NS, Theis FJ, et al. MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. Oncotarget. 2016;7:12937-50. doi:10.18632/oncotarget.7346. PMID:26887050
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun B, Zhao X, Zhao N, Sun R, Zhu D, Zhang Y, Li Y, Gu Q, Dong X, et al. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma. Oncotarget. 2016;7:24383-401. doi:10.18632/oncotarget.8328. PMID:27027434
   PubMed Web of Science ®Google Scholar
• Shen G, Lin Y, Yang X, Zhang J, Xu Z, Jia H. MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X. BMC Cancer. 2014;14:393. doi:10.1186/1471-2407-14-393. PMID:24890815
   PubMed Web of Science ®Google Scholar
• Siebzehnrubl FA, Silver DJ, Tugertimur B, Deleyrolle LP, Siebzehnrubl D, Sarkisian MR, Devers KG, Yachnis AT, Kupper MD, Neal D, et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med. 2013;5:1196-212. doi:10.1002/emmm.201302827. PMID:23818228
   PubMed Web of Science ®Google Scholar
• Ashizawa T, Akiyama Y, Miyata H, Iizuka A, Komiyama M, Kume A, Omiya M, Sugino T, Asai A, Hayashi N, et al. Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line. Int J Oncol. 2014;45:411-8. PMID:24820265
   PubMed Web of Science ®Google Scholar
• Tso JL, Yang S, Menjivar JC, Yamada K, Zhang Y, Hong I, Bui Y, Stream A, McBride WH, Liau LM, et al. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide. Mol Cancer. 2015;14:189. doi:10.1186/s12943-015-0459-1. PMID:26546412
   PubMed Web of Science ®Google Scholar
• Tang H, Zhao J, Zhang L, Zhuang Y, Liang P. SRPX2 enhances the Epithelial-Mesenchymal transition and temozolomide resistance in glioblastoma cells. Cell Mol Neurobiol. 2016;36:1067-76. doi:10.1007/s10571-015-0300-9. PMID:26643178
   PubMed Web of Science ®Google Scholar
• Yu F, Li G, Gao J, Sun Y, Liu P, Gao H, Li P, Lei T, Chen Y, Cheng Y, et al. SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance. Cell Prolif. 2016;49:195-206. doi:10.1111/cpr.12241. PMID:26923184
   PubMed Web of Science ®Google Scholar
• Wu N, Zhao X, Liu M, Liu H, Yao W, Zhang Y, Cao S, Lin X. Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PloS One. 2011;6:e16264. doi:10.1371/journal.pone.0016264. PMID:21264258
   PubMed Web of Science ®Google Scholar
• Zhu Y, Lu Y, Zhang Q, Liu JJ, Li TJ, Yang JR, Zeng C, Zhuang SM. MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Nucleic Acids Res. 2012;40:4615-25. doi:10.1093/nar/gkr1278. PMID:22210897
   PubMed Web of Science ®Google Scholar
• Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, Chen YC, Peng Y, Yao KT, Kung HF, et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res. 2011;71:225-33. doi:10.1158/0008-5472.CAN-10-1850. PMID:21199804
   PubMed Web of Science ®Google Scholar
• Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009;137:1005-17. doi:10.1016/j.cell.2009.04.021. PMID:19524505
   PubMed Web of Science ®Google Scholar
• Zhang B, Liu XX, He JR, Zhou CX, Guo M, He M, Li MF, Chen GQ, Zhao Q. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis. 2011;32:2-9. doi:10.1093/carcin/bgq209. PMID:20952513
   PubMed Web of Science ®Google Scholar
• Reuland SN, Smith SM, Bemis LT, Goldstein NB, Almeida AR, Partyka KA, Marquez VE, Zhang Q, Norris DA, Shellman YG. MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD). J Invest Dermatol. 2013;133:1286-93. doi:10.1038/jid.2012.400. PMID:23190898
   PubMed Web of Science ®Google Scholar
• Liu XX, Li XJ, Zhang B, Liang YJ, Zhou CX, Cao DX, He M, Chen GQ, He JR, Zhao Q. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Letters. 2011;585:1363-7. doi:10.1016/j.febslet.2011.04.018. PMID:21510944
   PubMed Web of Science ®Google Scholar
• Lin J, Zhang L, Huang H, Huang Y, Huang L, Wang J, Huang S, He L, Zhou Y, Jia W, et al. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4. Oncotarget. 2015;6:23793-806. doi:10.18632/oncotarget.4363. PMID:26204489
   PubMed Web of Science ®Google Scholar
• Li H, Sun Q, Han B, Yu X, Hu B, Hu S. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2. Int J Clin Exp Pathol. 2015;8:4782-90. PMID:26191168
   PubMed Web of Science ®Google Scholar
• Liang N, Zhou X, Zhao M, Zhao D, Zhu Z, Li S, Yang H. Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN. Acta Biochim Et Biophys Sinica. 2015;47:530-8. doi:10.1093/abbs/gmv046
   PubMed Web of Science ®Google Scholar
• Du JY, Wang LF, Wang Q, Yu LD. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells. Oncol Reports. 2015;33:1890-8
   PubMed Web of Science ®Google Scholar
• Cao J, Guo T, Dong Q, Zhang J, Li Y. miR-26b is downregulated in human tongue squamous cell carcinoma and regulates cell proliferation and metastasis through a COX-2-dependent mechanism. Oncol Reports. 2015;33:974-80
   PubMed Web of Science ®Google Scholar
• Zhang X, Wei C, Li J, Liu J, Qu J. MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1. Oncol Reports. 2017;37:1849-56
   PubMed Web of Science ®Google Scholar
• Liao H, Bai Y, Qiu S, Zheng L, Huang L, Liu T, Wang X, Liu Y, Xu N, Yan X, et al. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2. Oncotarget. 2015;6:8914-28. doi:10.18632/oncotarget.3563. PMID:25871397
   PubMed Web of Science ®Google Scholar
• Wu J, Cui H, Zhu Z, Wang L. MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5. Biochem Biophys Res Commun. 2016;478:1158-64. doi:10.1016/j.bbrc.2016.08.085. PMID:27545608
   PubMed Web of Science ®Google Scholar
• Dong N, Xu B, Benya SR, Tang X. MiRNA-26b inhibits the proliferation, migration, and epithelial-mesenchymal transition of lens epithelial cells. Mol Cell Biochem. 2014;396:229-38. doi:10.1007/s11010-014-2158-4. PMID:25063219
   PubMed Web of Science ®Google Scholar
• Zhao N, Wang R, Zhou L, Zhu Y, Gong J, Zhuang SM. MicroRNA-26b suppresses the NF-kappaB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. Mol Cancer. 2014;13:35. doi:10.1186/1476-4598-13-35. PMID:24565101
   PubMed Web of Science ®Google Scholar
• Jin F, Wang Y, Li M, Zhu Y, Liang H, Wang C, Wang F, Zhang CY, Zen K, Li L. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy. Cell Death Dis. 2017;8:e2540. doi:10.1038/cddis.2016.461. PMID:28079894
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Schmitz U, Wolkenhauer O, Schonherr M, Raatz Y, Kunz M. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma. Oncogene. 2013;32:3175-83. doi:10.1038/onc.2012.324. PMID:22847610
   PubMed Web of Science ®Google Scholar
• Hamilton DH, Huang B, Fernando RI, Tsang KY, Palena C. WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition. Cancer Res. 2014;74:2510-9. doi:10.1158/0008-5472.CAN-13-1894. PMID:24626094
   PubMed Web of Science ®Google Scholar
• Zhao W, Liu S, Dou Q, Li C, Du J, Ren W. The role and mechanism of WEE1 on the cisplatin resistance reversal of the HepG2/DDP human hepatic cancer cell line. Oncol Letters. 2015;10:3081-6
   PubMed Web of Science ®Google Scholar
• Matheson CJ, Venkataraman S, Amani V, Harris PS, Backos DS, Donson AM, Wempe MF, Foreman NK, Vibhakar R, Reigan P. A WEE1 inhibitor analog of AZD1775 maintains synergy with cisplatin and demonstrates reduced single-agent cytotoxicity in medulloblastoma cells. ACS Chem Biol. 2016;11:921-30. doi:10.1021/acschembio.5b00725. PMID:26745241
   PubMed Web of Science ®Google Scholar
• Jhuraney A, Woods NT, Wright G, Rix L, Kinose F, Kroeger JL, Remily-Wood E, Cress WD, Koomen JM, Brantley SG, et al. PAXIP1 potentiates the combination of WEE1 inhibitor AZD1775 and platinum agents in lung cancer. Mol Cancer Ther. 2016;15:1669-81. doi:10.1158/1535-7163.MCT-15-0182. PMID:27196765
   PubMed Web of Science ®Google Scholar
• Wang L, Hou Y, Yin X, Su J, Zhao Z, Ye X, Zhou X, Zhou L, Wang Z. Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells. Oncotarget. 2016;7:69770-82. PMID:27626499
   PubMed Web of Science ®Google Scholar
• Wang L, Ye X, Cai X, Su J, Ma R, Yin X, Zhou X, Li H, Wang Z. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells. Oncotarget. 2015;6:18027-37. doi:10.18632/oncotarget.4090. PMID:26046466
   PubMed Web of Science ®Google Scholar
• Ma J, Fang B, Zeng F, Ma C, Pang H, Cheng L, Shi Y, Wang H, Yin B, Xia J, et al. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Oncotarget. 2015;6:1740-9. doi:10.18632/oncotarget.2714. PMID:25638153
   PubMed Web of Science ®Google Scholar